PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.40%
Positive revenue growth while ECL.AX is negative. John Neff might see a notable competitive edge here.
313.44%
Positive gross profit growth while ECL.AX is negative. John Neff would see a clear operational edge over the competitor.
1367.46%
Positive EBIT growth while ECL.AX is negative. John Neff might see a substantial edge in operational management.
1367.46%
Positive operating income growth while ECL.AX is negative. John Neff might view this as a competitive edge in operations.
2002.95%
Positive net income growth while ECL.AX is negative. John Neff might see a big relative performance advantage.
1300.00%
Positive EPS growth while ECL.AX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1300.00%
Positive diluted EPS growth while ECL.AX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
1.23%
Share count expansion well above ECL.AX's 0.02%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-17.11%
Reduced diluted shares while ECL.AX is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
111.33%
OCF growth above 1.5x ECL.AX's 1.28%. David Dodd would confirm a clear edge in underlying cash generation.
282.53%
Positive FCF growth while ECL.AX is negative. John Neff would see a strong competitive edge in net cash generation.
350.78%
Positive 10Y revenue/share CAGR while ECL.AX is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
343.23%
Positive 5Y CAGR while ECL.AX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
70.38%
Positive 3Y CAGR while ECL.AX is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
3628.75%
10Y OCF/share CAGR in line with ECL.AX's 3865.29%. Walter Schloss would see both as similarly efficient over the decade.
1723.11%
5Y OCF/share CAGR at 50-75% of ECL.AX's 2571.31%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
-1.35%
Negative 3Y OCF/share CAGR while ECL.AX stands at 249.42%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
550.00%
Positive 10Y CAGR while ECL.AX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
1250.00%
Positive 5Y CAGR while ECL.AX is negative. John Neff might view this as a strong mid-term relative advantage.
170.00%
Positive short-term CAGR while ECL.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
20909.17%
10Y equity/share CAGR above 1.5x ECL.AX's 52.95%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
115.51%
5Y equity/share CAGR above 1.5x ECL.AX's 66.94%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
37.12%
3Y equity/share CAGR at 75-90% of ECL.AX's 42.35%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
119.77%
Our AR growth while ECL.AX is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
1178.20%
We show growth while ECL.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
28.54%
Asset growth above 1.5x ECL.AX's 3.96%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
40.45%
BV/share growth above 1.5x ECL.AX's 5.70%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-49.27%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
51.29%
We expand SG&A while ECL.AX cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.